Withers continues its rapid growth strategy in the life sciences sector in Boston with the arrival of new partners Tom Meyers and Zachary Hyde.

Tom and Zack work primarily with clients in the life sciences sector. They develop, implement, and monetize innovation, spanning areas such as diagnostics, medical devices, life science tools and technology platforms, genomics and therapeutics.

With over 20 years' experience working with life sciences clients, Tom is recognised for creating the foundational IP strategies for numerous successful companies. Alongside senior roles at Brown Rudnick and Cooley, Tom also served as Vice President and General Counsel of Helicos BioSciences Corporation.

Jeremy Wakeham, CEO of Withers' Business division, comments: "We are seeing more and more interest in investing private capital in the life sciences sector and have been actively building on our capabilities on a global scale in response to the needs of our clients. Our Boston practice is a focal point in representing the industry's entrepreneurs and innovators. Our life sciences, venture capital and corporate teams in the city continue to go from strength to strength, with Tom and Zack bringing outstanding reputations and a strong following to our well-established international life sciences team. Having already worked with members of our UK Withers tech team in the past, the transatlantic flow of work will only strengthen as more inter-connections are made."

Tom Meyers adds: "We love what Withers is doing in Boston and around the world – building a hub of excellence for life science and pharma businesses and the investors that back them. Zack and I see huge opportunities to assist clients around the world in growing and increasing the value of their businesses. Withers is in a unique global position to help life science companies succeed and we are thrilled to be part of the team."

View our Boston page HERE.